In a lawsuit filed Thursday in Manhattan federal court, Northwest Biotherapeutics alleged Citadel Securities, Susquehanna International Group, Virtu Americas, Canaccord Genuity and other Wall Street market makers repeatedly engaged in "spoofing," where traders place orders with an intent to fool other investors and manipulate the share price, Justin Baer of Wall Street Journal reports. Reference Link
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NWBO: